Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sage Therapeutics, Inc. - Common Stock
(NQ:
SAGE
)
8.680
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sage Therapeutics, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
↗
August 07, 2023
Benzinga
Via
Benzinga
Why Sage Therapeutics Shares Are Sinking Monday
↗
August 07, 2023
Sage Therapeutics Inc (NASDAQ: SAGE) shares are trading lower Monday after the company announced the FDA issued a Complete Response Letter (CRL) for one of the company's
Via
Benzinga
SOVO Stock Alert: Campbell Soup Is Buying Sovos Brands for $2.7 Billion
↗
August 07, 2023
Sovos Brands (SOVO) stock is rising higher on Monday following news that Campbell Soup (CPB) is acquiring the Italian sauces company.
Via
InvestorPlace
Dow Jumps 250 Points; Tyson Foods Posts Downbeat Results
↗
August 07, 2023
U.S. stocks were higher this morning, with the Dow Jones gaining more than 250 points on Monday. Following the market opening Monday, the Dow traded up 0.77% to 35,334.81 while the NASDAQ rose 0.42% to...
Via
Benzinga
What 10 Analyst Ratings Have To Say About Sage Therapeutics
↗
July 27, 2023
Via
Benzinga
Expert Ratings for Sage Therapeutics
↗
May 09, 2023
Via
Benzinga
Sage Therapeutics's Earnings Outlook
↗
May 01, 2023
Via
Benzinga
Why Is Sage Therapeutics (SAGE) Stock Down 48% Today?
↗
August 07, 2023
Sage Therapeutics (SAGE) stock isn't doing the best on Monday after the FDA weighed in on the company's depression drug zuranolone.
Via
InvestorPlace
Why Sage Lost Half Its Value After The FDA Approved Its Depression Drug
↗
August 07, 2023
The company gained approval for the first oral treatment for postpartum depression.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 07, 2023
Via
Benzinga
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
↗
August 07, 2023
The FDA approved Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc's (NASDAQ: BIIB) Zurzuvae (zuranolone) 50 mg for adults with
Via
Benzinga
Wayfair To Rally Over 32%? Here Are 10 Other Analyst Forecasts For Monday
↗
August 07, 2023
Needham raised the price target for MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) from $65 to $84. Needham analyst Quinn Bolton maintained a Buy rating. MACOM Technology shares rose 0.1% to...
Via
Benzinga
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
August 07, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Host Business Update Webcast and Announce Second Quarter Financial Results on Monday, August 7, 2023
August 04, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder
August 04, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
July 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
↗
July 27, 2023
Via
Benzinga
Why Sage Therapeutics Stock Is Tumbling Today
↗
July 26, 2023
A partner's perceived lack of enthusiasm for an upcoming regulatory decision is spooking investors today.
Via
The Motley Fool
Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
July 26, 2023
Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 26, 2023
Via
Benzinga
Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at Upcoming May Investor Conferences
May 03, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
May 02, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023
April 18, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at the Stifel 2023 CNS Days
March 22, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics Appoints Jessica Federer to Board of Directors
March 16, 2023
From
Sage Therapeutics, Inc.
Via
Business Wire
Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone
↗
March 13, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
↗
March 13, 2023
Via
Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 13, 2023
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
Via
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
↗
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
